Showing results (1461-1470 of 3,121) with videos related to

Sort By:
Pageof 313
Mini Reviews in Medicinal Chemistry|April 23, 2021
Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief ReviewS Yuvaraj, B R Prashantha Kumar
Mini Reviews in Medicinal Chemistry|April 23, 2021
Role of GLP-1 Analogs in the Management of Diabetes and its Secondary ComplicationPonnurengam Malliappan Sivakumar, B Premkumar, Veluchamy Prabhawathi, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2012
Antioxidant evaluation of heterocyclic compounds by cytokinesis-block micronucleus assayDejan Godevac, Vele Tesević, Vlatka Vajs, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2012
Menthol--pharmacology of an important naturally medicinal "cool"Joseph A Farco, Oliver Grundmann
Mini Reviews in Medicinal Chemistry|August 7, 2025
Recent Advances in the Therapeutic Prospective of Heterocyclic Derivatives as COX-2 Inhibitors (2019-Present)Afaf Y Khormi, Amani M R Alsaedi, Thoraya A Farghaly, et al.
Mini Reviews in Medicinal Chemistry|October 30, 2025
Regulatory T Cells: Subtle and Promising Achilles' Heel of Psoriasis - Atherosclerosis ComorbidityFangshun Tan, Zhifeng Song, Liang Zhao, et al.
Mini Reviews in Medicinal Chemistry|October 30, 2025
Targeting Microbiome-Derived Exosomes to Overcome Cancer Therapy Resistance: Mechanisms, Implications, and OpportunitiesVaibhav Singh, Ekta Shirbhate, Rakesh Kore, et al.
Mini Reviews in Medicinal Chemistry|October 23, 2025
Exploring Indole-Based Molecules as Novel Therapeutics for Parkinson's Disease: A Comprehensive ReviewRitam Mondal, Deepika Paliwal, Aman Thakur, et al.
Mini Reviews in Medicinal Chemistry|July 10, 2025
Potential of MAO-B Inhibitors with Multi-Target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative DisordersMoataz A Shaldam, Simone Carradori, Francesco Melfi, et al.
Mini Reviews in Medicinal Chemistry|September 19, 2025
Therapeutic Potential of Underexplored Phytoconstituents Targeting Molecular Pathways in Breast Cancer SubtypesShruthi Laya S, Jubie Selvaraj, Prisil Naveentha X, et al.
Pageof 313